Redhill Biopharma
RDHL
#11160
Rank
HK$19.57 M
Marketcap
HK$2.20
Share price
-13.08%
Change (1 day)
-72.79%
Change (1 year)

Redhill Biopharma (RDHL) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : HK$0.21 Billion

According to Redhill Biopharma's latest financial reports the company's total liabilities are HK$0.21 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Redhill Biopharma - Total liabilities on balance sheet (from 2011 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31HK$0.16 B-7.05%
2024-12-31HK$0.17 B7.69%
2023-12-31HK$0.16 B-89.88%
2022-12-31HK$1.61 B20.53%
2021-12-31HK$1.34 B4.17%
2020-12-31HK$1.28 B1074.79%
2019-12-31HK$0.10 B24.9%
2018-12-31HK$87.9 M-8.37%
2017-12-31HK$95.92 M7.47%
2016-12-31HK$89.26 M70.59%
2015-12-31HK$52.32 M75.45%
2014-12-31HK$29.82 M59.26%
2013-12-31HK$18.72 M124.12%
2012-12-31HK$8.35 M-23.1%
2011-12-31HK$10.86 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sanofi
SNY
HK$532.27 B 248,140.41%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$688.39 B 320,954.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$554.58 B 258,548.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$251.62 B 117,254.59%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
HK$3.01 B 1,304.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel